Comparison of COVID-۱۹ Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking
Publish place: Trends in Pharmaceutical Sciences، Vol: 7، Issue: 2
Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 227
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_TIPS-7-2_006
تاریخ نمایه سازی: 20 مرداد 1400
Abstract:
The Covid-۱۹ pandemic is new challenge all around the world. This pandemic provides an emergency development of vaccines and drugs against this virus. As main proteases of CoV-۱۹ have essential roles in the transmission and virulence of the virus. So, this enzyme has been considered as a critical target to inhibit COVID-۱۹. Natural compounds are well known as rich sources of antiviral drugs due to their structural diversity and safety. In this study, we have screened thirteen phenolic acids (Cinnamic acid and Hydroxy benzoic derivatives) to compare the potential inhibitory activity of these molecules against COVID-۱۹ protease. Systematic molecular docking simulation was done using AutoDock ۴.۲.۶ to achieve the binding affinities and interactions between phenolic acids and protease. Cinnamic acids are better protease inhibitors in comparison with benzoic acid derivatives. Among Cinnamic acid derivatives, Rosmarinic acid exhibited the minimum Gibbs binding energy and highest docking scores. Also, Chorgenic > Ellagic > Ferulic acid could more effective respectively . According to obtained results, Rosmarinic acid has formed strong hydrogen bonding interaction with His۱۶۳A, Ser۱۴۴A, Cys۱۴۵A, Gly۱۴۳A and Thr۲۶A, while the propyl cyclohexadione of Rosmarinic acid formed hydrophobic interaction with residue Gly ۱۴۳A. It seems that Cinnamic acid derivatives of phenolic acid, particularly Rosmarinic acid could be efficient SARS-CoV ۳CLpro inhibitors. In the next step, it is necessary to survey the effect of these natural products in inhibition of SARS-CoV replication through cell culture and in vitro assays. This study will improve preclinical knowledge about potential of natural compounds as SARS-CoV inhibitors.
Keywords:
Authors
Razie Sabet
Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
Mohsen Sisakht
Department of Medical Biochemistry, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Leila Emami
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Zahra Sabahi
Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :